Medtronic MDT Business Segments
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| Net Sales by Business | |||||
| Cardiovascular | $13.98B+12.0% | $12.48B+5.5% | $11.83B+2.7% | $11.52B+1.4% | |
| Diabetes | $3.11B+13.0% | $2.76B+10.8% | $2.49B+9.9% | $2.26B-3.3% | |
| Medical Surgical | $8.81B+4.8% | $8.41B-0.1% | $8.42B+5.4% | $7.99B-5.7% | |
| Neuroscience | $10.29B+4.5% | $9.85B+4.7% | $9.41B+5.0% | $8.96B+2.0% | |
| Other Operating Segments | $135M-1.5% | $137M-38.0% | $221M— | —— | |
| Net Sales by Geography | |||||
| Ireland | $143M+22.2% | $117M+4.5% | $112M+13.1% | $99M-2.9% | |
| Rest of world | $18.12B+11.5% | $16.25B+3.6% | $15.69B+6.3% | $14.76B-4.5% | |
| United States | $18.1B+5.4% | $17.17B+3.7% | $16.56B+1.2% | $16.37B+1.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Medtronic break its business down?
- Medtronic (MDT) reports net sales by business across 6 parts — Cardiovascular, Diabetes, Medical Surgical, Neuroscience and Other operating segment. Each is extracted from the segment footnotes and tracked over time.
- Where does Medtronic's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Medtronic's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
